Annovis Bio Inc (ANVS) is -41.48% away from 50-day simple Moving Average despite all headwinds

As on Wednesday, Annovis Bio Inc (NYSE: ANVS) got off with the flyer as it spiked 9.69% to $6.11, before settling in for the price of $5.57 at the close. Taking a more long-term approach, ANVS posted a 52-week range of $5.23-$22.49.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Meanwhile, its Annual Earning per share during the time was -126.41%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 55.84%. This publicly-traded company’s shares outstanding now amounts to $10.52 million, simultaneously with a float of $8.14 million. The organization now has a market capitalization sitting at $67.27 million. At the time of writing, stock’s 50-day Moving Average stood at $10.36, while the 200-day Moving Average is $10.59.

Annovis Bio Inc (ANVS) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Annovis Bio Inc’s current insider ownership accounts for 26.05%, in contrast to 11.40% institutional ownership.

Annovis Bio Inc (ANVS) Earnings and Revenue Records

Annovis Bio Inc’s EPS increase for this current 12-month fiscal period is 55.84% and is forecasted to reach -2.49 in the upcoming year.

Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators

Let’s observe the current performance indicators for Annovis Bio Inc (ANVS). It’s Quick Ratio in the last reported quarter now stands at 2.39. The Stock has managed to achieve an average true range (ATR) of 2.14.

In the same vein, ANVS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.22, a figure that is expected to reach -0.83 in the next quarter, and analysts are predicting that it will be -2.49 at the market close of one year from today.

Technical Analysis of Annovis Bio Inc (ANVS)

Through scrutinizing the latest numbers posted by the [Annovis Bio Inc, ANVS], it can be observed that its last 5-days Average volume of 2.85 million was better the volume of 0.42 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 7.38% While, its Average True Range was 2.63.

Raw Stochastic average of Annovis Bio Inc (ANVS) in the period of the previous 100 days is set at 5.10%, which indicates a major fall in contrast to 5.96% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 425.00% that was higher than 200.42% volatility it exhibited in the past 100-days period.